DRS
Leonardo DRS, Inc.
DRS's fundamentals are strong: earnings per share grew 37% and free cash flow grew 30%. At 26x earnings, it's trading in line with its usual 28x. Analysts expect that strong growth to continue.
DRS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
DRS's revenue, profitability, cash flow and balance sheet are all currently healthy.
DRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9x | $12.28 | -66% |
| Forward | 24x | $35.66 | — |
| Current | 26x | $35.66 | — |
| Fair | 27x | $36.60 | +2.6% |
| Expensive | 43x | $58.75 | +65% |
Historical ranges are pointers, not guarantees.
DRS's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.
DRS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for DRS, with profitability improving.
DRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.47 | +8.4% |
| Q3 2026 | $1.36 | +37% |
| Q2 2026 | $1.19 | +27% |
| Q1 2026 | $1.07 | +22% |
| Q4 2025 | $1.03 | +29% |
| Q3 2025 | $0.99 | +34% |
| Q2 2025 | $0.94 | +32% |
| Q1 2025 | $0.88 | +26% |
| Q4 2024 | $0.80 | +25% |
DRS's earnings per share have fallen from their peak: $1.36 over the past year, against $2.74 in late 2022.
DRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +11% |
| Q2 2026 | $913M | +10% |
| Q1 2026 | $846M | +5.9% |
| Q4 2025 | $1.1B | +8.1% |
| Q3 2025 | $960M | +18% |
| Q2 2025 | $829M | +10% |
| Q1 2025 | $799M | +16% |
| Q4 2024 | $981M | +5.9% |
DRS's revenue has grown year over year for 14 quarters in a row: $1.1B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +1.2 points |
| Q2 2026 | 11% | +2.7 points |
| Q1 2026 | 9.1% | +1.7 points |
| Q4 2025 | 12% | -0.3 points |
| Q3 2025 | 9.7% | +0.4 points |
| Q2 2025 | 8.4% | +1.1 points |
| Q1 2025 | 7.4% | +1.1 points |
| Q4 2024 | 12% | +0.9 points |
DRS's operating margin was 11% last quarter, up 1.2 points from the same quarter a year ago.
DRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58M | -25% |
| Q2 2026 | $6M | +$62M |
| Q1 2026 | -$96M | +$74M |
| Q4 2025 | $376M | -9.2% |
| Q3 2025 | $77M | +64% |
| Q2 2025 | -$56M | -$56M |
| Q1 2025 | -$170M | +$105M |
| Q4 2024 | $414M | -17% |
DRS generated $344M in free cash flow over the past year, up 30% from the year before.
DRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -600K shares |
| 1 year | 0% | -100K shares |
| 3 years | +1.2% | +3.3M shares |
| 5 years | +85% | +123M shares |
| Available history | +85% | +123M shares |
DRS has 268M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $12M |
| Q2 2026 | $12M |
| Q1 2026 | $4M |
| Q4 2025 | $11M |
| Q3 2025 | $10M |
| Q2 2025 | $11M |
| Q1 2025 | $3M |
| Q4 2024 | $15M |
DRS spent $39M buying back its own shares over the past year, about the same as the year before.
DRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
DRS has more cash than debt.
DRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 21.1 | Neutral |
DRS's weekly RSI is 42 (neutral) and its Stochastic is 21 (neutral).
DRS PE vs Industrials Sector
| Metric | DRS | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 9.1% above |
| PE % | 49 | 58 | 9 pts below |
DRS is trading at 26x earnings, in line with the Industrials sector's median of 24x.
DRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.9 | 0.8% below |
| 20 week MA | $39.7 | 10% below |
| 50 week MA | $41.0 | 13% below |
| 100 week MA | $39.8 | 10% below |
| 200 week MA | $30.4 | 17% above |
DRS has fallen below most of its moving averages, though it's still 17% above its 200-week average.
DRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.35 | $10.3 | +92% |
| 2021 | $10.3 | $9.45 | -8% |
| 2022 | $9.45 | $13.2 | +39% |
| 2023 | $13.2 | $20.0 | +52% |
| 2024 | $20.0 | $32.5 | +62% |
| 2025 | $32.5 | $34.3 | +5.3% |
| 2026 YTD | $34.3 | $35.7 | +4% |
DRS has finished higher in five of the last six years, three of them by more than 50%. It's up 4% so far in 2026.